178 related articles for article (PubMed ID: 8247256)
1. Binding in vivo of selective mu and delta opioid agonists: localization by autoradiography.
Mokhtari M; Tafani JA; Zajac JM
Neuropeptides; 1993 Sep; 25(3):183-91. PubMed ID: 8247256
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
3. [125I][D-Ala2]deltorphin-I: a high affinity, delta-selective opioid receptor ligand.
Dupin S; Tafani JA; Mazarguil H; Zajac JM
Peptides; 1991; 12(4):825-30. PubMed ID: 1664947
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
Qi JA; Mosberg HI; Porreca F
Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
[TBL] [Abstract][Full Text] [Related]
5. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
[TBL] [Abstract][Full Text] [Related]
6. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse.
Raffa RB; Martinez RP; Porreca F
Eur J Pharmacol; 1992 Jun; 216(3):453-6. PubMed ID: 1330585
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J
Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
Negri L; Noviello L; Noviello V
Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice.
Kamei J; Iwamoto Y; Suzuki T; Nagase H; Misawa M; Kasuya Y
Eur J Pharmacol; 1993 Mar; 234(1):117-20. PubMed ID: 8386091
[TBL] [Abstract][Full Text] [Related]
10. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
11. Opioid receptor selectivity alteration by single residue replacement: synthesis and activity profile of [Dmt1]deltorphin B.
Guerrini R; Capasso A; Sorrentino L; Anacardio R; Bryant SD; Lazarus LH; Attila M; Salvadori S
Eur J Pharmacol; 1996 Apr; 302(1-3):37-42. PubMed ID: 8790989
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of mu- and delta-opioid antinociception by neuropeptide FF receptors in young mice.
Desprat C; Zajac JM
Neuropeptides; 1997 Feb; 31(1):1-7. PubMed ID: 9574828
[TBL] [Abstract][Full Text] [Related]
13. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
14. Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors.
Wild KD; Horan PJ; Misicka A; Lipkowski A; Haaseth RC; Matsunaga TO; Hruby VJ; Toth G; Borsodi A; Yamamura HI
Eur J Pharmacol; 1993 Jun; 246(1):25-31. PubMed ID: 8394818
[TBL] [Abstract][Full Text] [Related]
15. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
16. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
[TBL] [Abstract][Full Text] [Related]
17. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
Gyires K; Rónai AZ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
[TBL] [Abstract][Full Text] [Related]
18. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone.
Gouarderes C; Jhamandas K; Cridland R; Cros J; Quirion R; Zajac JM
Neuroscience; 1993 Jun; 54(3):799-807. PubMed ID: 7687333
[TBL] [Abstract][Full Text] [Related]
19. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
20. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
Sánchez-Blázquez P; García-España A; Garzón J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
